US Stock MarketDetailed Quotes

APTX Aptinyx

Watchlist
  • 0.096000
  • 0.0000000.00%
15min DelayClose Dec 29 16:00 ET
6.50MMarket Cap-0.10P/E (TTM)

About Aptinyx Company

Aptinyx Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders. Its pipeline products are NYX-2925, NYX-458, and NYX-783. NYX-2925 is a novel, oral, small-molecule NMDA receptor modulator in clinical development as a therapy for chronic pain. NYX-2925 works by enhancing synaptic plasticity, a mechanism uniquely suited to addressing chronic pain, and NYX-783 is an NMDA receptor modulating small molecule in clinical development as a therapy for post-traumatic stress disorder.

Company Profile

SymbolAPTX
Company NameAptinyx
Issue Price16.00
CEOMr. Andrew Kidd
MarketPink Market
Employees12
Fiscal Year Ends12-31

Company Executives

  • Name
  • Position
  • Salary
  • Andrew Kidd
  • Interim Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer
  • --
  • Craig R. Jalbert
  • Director, President, Treasurer, Corporate Secretary
  • --
  • Robert J. Hombach
  • Independent Director
  • --
Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.